#Mixing vaccines: Study from #Spain indicates it is likely safe to have taken #AstraZeneca then switch to the #BNT1622b vaccine for 2nd dose—found to be “highly immunogenic & safe.” Neutralization with Pfizer for 2nd dose increased 7 folds 1/
Presence of IgG Abs was between 30 to 40 times higher in people who got the follow-up #BNT1622b shot than in a control group who only received one #AstraZeneca dose 2/

english.elpais.com/society/2021-0…
Meanwhile, the presence of #Neutralising Abs arose 7 folds after a #Pfizer dose, significantly more than the doubling effect observed after a 2nd AZ shot 3/

cp24.com/world/astrazen…
What’s more, the combination of the #Pfizer and #AstraZeneca vaccines did not increase side effects 4/
In a U.K. "mix-and-match" study, people vaccinated with a shot of #Pfizer's vaccine followed by #AZ or vice versa, were more likely to report mild or moderate symptoms than if they received two of the same type 5/

news24.com/health24/medic…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vipin M. Vashishtha

Vipin M. Vashishtha Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @vipintukur

21 May
Antibodies or the T-cells?

Which arm is crucial for viral clearance & protection against #SARSCoV2? 1/ Image
Early on in the #pandemic questions arose regarding how #SARSCoV2 is cleared during acute/primary infection & what aspects of the #adaptive immune were necessary and sufficient for protection from repeat infection 2/
Using mouse models of SARSCoV2,@BenIsraelow Rt al demonstrate that both humoral and cellular adaptive immunity contributes to viral clearance in the setting of primary infection 3/ ImageImage
Read 9 tweets
20 May
How the #Covid pandemic ends: The truth of the matter is that pandemics always end. And to date #vaccines have never played a significant role in ending them........ 1/statnews.com/2021/05/19/how…
......that doesn’t mean #vaccines aren’t playing a critical role this time. Far fewer people will die from #Covid19 because of them 2/
Experience from the last 4 pandemics would suggest that viruses morph from pandemic pathogens to endemic sources of disease within a year & a half or two of emerging. But all of those pandemics were flu pandemics. A different pathogen could mean we’ll see a different pattern 3/
Read 6 tweets
13 May
The #Indian variant (#B16172) may be the most transmissible variant yet identified!!
This variant is 60% more transmissible than the #UK variant (#B117), & 2.6 times more transmissible than the original strain (B1)!
The #B16172 has now become the dominant variant in almost all key states on India. Data patchy (n=4480 since Jan. 2021 of which 1690 B.1.617+) but clear patterns. Data courtesy @TWenseleers
According to a new modelling study shared by @TWenseleers, the Indian VOC #B16172 would have a growth rate advantage of 7% per day over B.1.617.1 or of 10% per day relative to the UK variant B.1.1.7.
Read 5 tweets
12 May
#B16171 variant is 6.8-fold less susceptible to neutralization by sera from infection & vaccinated (Pfizer & Moderna) subjects. Despite this, most of the sera from convalescents (79%) & all from vaccinated subjects were still able to neutralize the variant biorxiv.org/content/10.110…
#Covaxin retains efficacy against #B1617: Only minimal reductions in the neutralization observed against B1617; Neutralization reduction by a factor of 1.95 & 1.8 was observed against the B1617 variant for B1 (D614G) & B117 variant, respectively. biorxiv.org/content/10.110…
#B16171 variant is highly pathogenic in hamsters than B1 (D614G) variant! B1617 demonstrates higher pathogenicity evident with reduced body weight, higher viral load in lungs & pronounced lung lesions as compared to B1 biorxiv.org/content/10.110…
Read 4 tweets
12 May
A very interesting yet a bit complicated paper. First, let’s go through the key findings of the paper:

1) the distribution of viral loads observed in asymptomatic population was indistinguishable from what has been reported in hospitalized populations 1/
2) regardless of symptomatic status, approx. 50% of individuals who test positive for #SARSCoV2 seem to be in noninfectious phases of the infection 2/ pnas.org/content/118/21…
3) just 2% of infected individuals carry 90% of the virions circulating within communities, serving as viral “supercarriers” & likely also superspreaders 3/

pnas.org/content/118/21…
Read 9 tweets
10 May
The WHO declared a coronavirus variant first identified in India, B.1.617, as a “variant of concern,” the agency’s fourth such designation wsj.com/articles/coron…
One can understand the gravity of this announcement: The Indian variant, #B1717 is now clubbed with UK #B117, SA #B1351 & Brazil’s #P1
I think this data is saying "Take B.1.617 very seriously and surge test, contact trace, support isolation of cases & contacts, ring vaccinate - NOW" @chrischirp Look, experts from UK are sounding alert on a variant originated from here! And what was our response?
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(